TAK-660-403

Name: TAK-660-403
Author: ERT,INC

by ERT,INC

0 ratings

🏥 Medical

Free

Rating summary

Details

Released
Updated
Version
Compatibility
Age Rating
Size
Devices
Data updated
Languages

February 24, 2020
January 9, 2024
1.2
iOS 10.0+
4+
38.15MB
iPhone, iPad, iPod
5 months ago
English

Developer

ERT,INC

✨Promote your app ✨

📝3+ tags

Tags↘︎

🔄6+ apps

Alternatives↘︎

📦w/o updates

Updates frequency↘︎

🖼️Get Icon

Icons↘︎

About

An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)